| Hannaford Food & Drug #8223 | |
| 7 Hannaford Dr, Westbrook, Maine 04092 | |
| (207) 854-1294 |
| Name | Hannaford Food & Drug #8223 |
|---|---|
| Organization Name | Hannaford Bros. Co., Llc |
| Location | 7 Hannaford Dr, Westbrook, Maine 04092 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (207) 854-1294 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new paper published online in the Annals of the American Thoracic Society describes a "virtual" recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses.
It is well appreciated that facial expressions play a major role in non-verbal social communication among humans and other primates, because faces provide rapid access to information about the identity as well as the internal states and intentions of others.
University of Massachusetts Amherst Distinguished Professor David Julian McClements was honored Monday in Hillerød, Denmark, with the 2019 Nils Foss Excellence Prize for his pioneering work in food design and nanotechnology.
Autism spectrum disorders (ASD) are neurodevelopmental disorders typically characterized by difficulties in social interactions and delayed or abnormal language development. Although ASD reportedly affects 1 in 88 people in the United States, to date there have been no distinctive biomarkers to diagnose the disease.
Exelixis, Inc. today reported top-line results from the ongoing phase 3 clinical trial of cabozantinib in patients with advanced medullary thyroid cancer (MTC), known as the EXAM trial.
› Verified 7 days ago
| NPI Number | 1386752772 |
| Organization Name | HANNAFORD BROS CO LLC |
| Doing Business As | HANNAFORD FOOD AND DRUG |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7 Hannaford Dr, Westbrook, ME 04092 |
| Phone Number | 207-854-1294 |
News Archive
A new paper published online in the Annals of the American Thoracic Society describes a "virtual" recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses.
It is well appreciated that facial expressions play a major role in non-verbal social communication among humans and other primates, because faces provide rapid access to information about the identity as well as the internal states and intentions of others.
University of Massachusetts Amherst Distinguished Professor David Julian McClements was honored Monday in Hillerød, Denmark, with the 2019 Nils Foss Excellence Prize for his pioneering work in food design and nanotechnology.
Autism spectrum disorders (ASD) are neurodevelopmental disorders typically characterized by difficulties in social interactions and delayed or abnormal language development. Although ASD reportedly affects 1 in 88 people in the United States, to date there have been no distinctive biomarkers to diagnose the disease.
Exelixis, Inc. today reported top-line results from the ongoing phase 3 clinical trial of cabozantinib in patients with advanced medullary thyroid cancer (MTC), known as the EXAM trial.
› Verified 7 days ago
News Archive
A new paper published online in the Annals of the American Thoracic Society describes a "virtual" recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses.
It is well appreciated that facial expressions play a major role in non-verbal social communication among humans and other primates, because faces provide rapid access to information about the identity as well as the internal states and intentions of others.
University of Massachusetts Amherst Distinguished Professor David Julian McClements was honored Monday in Hillerød, Denmark, with the 2019 Nils Foss Excellence Prize for his pioneering work in food design and nanotechnology.
Autism spectrum disorders (ASD) are neurodevelopmental disorders typically characterized by difficulties in social interactions and delayed or abnormal language development. Although ASD reportedly affects 1 in 88 people in the United States, to date there have been no distinctive biomarkers to diagnose the disease.
Exelixis, Inc. today reported top-line results from the ongoing phase 3 clinical trial of cabozantinib in patients with advanced medullary thyroid cancer (MTC), known as the EXAM trial.
› Verified 7 days ago
Cvs Pharmacy #00803 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 870 Main St, Westbrook, Maine 04092 Phone: (207) 854-8443 | |
Hannaford Food & Drug #8223 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7 Hannaford Dr, Westbrook, Maine 04092 Phone: (207) 854-1294 | |
Osco Pharmacy #0623 Type: Medicare Supplier Location: 31 Main St, Westbrook, Maine 04092 Phone: (207) 857-9298 | |
Omnicare Of Maine Type: Long Term Care Pharmacy Location: 39 Eisenhower Dr, Westbrook, Maine 04092 Phone: (207) 854-6400 | |
Walgreens #19078 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 465 Main St, Westbrook, Maine 04092 Phone: (207) 854-9103 |